Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers-Reference-Cited by-同舟云学术

Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Tata Angela¹^ORCID,Dodard Garvin¹^ORCID,Fugère Céline¹,Leget Corinne²,Ors Mélody²,Rossi Benjamin²,Vivier Eric²³⁴^ORCID,Brossay Laurent¹⁵^ORCID

Affiliation:

1. Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University Alpert Medical School, Providence, Rhode Island, USA

2. Innate Pharma Research Labs., Marseille, France

3. Centre d’Immunologie De Marseille-Luminy, Aix Marseille Université, Marseille, France

4. Service d’Immunologie, Hôpital De La Timone, Assistance Publique-Hôpitaux De Marseille, Marseille, France

5. Lead Contact

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1933808

Reference53 articles.

1. Coinhibitory Pathways in Immunotherapy for Cancer

2. Neoantigens in cancer immunotherapy

3. The future of immune checkpoint therapy

4. The PD-1–PD-L pathway in immunological tolerance

5. PD-1 blockade induces responses by inhibiting adaptive immune resistance

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide analyses reveal the contribution of somatic variants to the immune landscape of multiple cancer types;PLOS Genetics;2024-01-19

2. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy;Molecular Cancer;2023-11-11

3. Innate lymphoid cells: a new key player in atopic dermatitis;Frontiers in Immunology;2023-10-16

4. KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir;Cell Reports Medicine;2023-10

5. KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response;Journal for ImmunoTherapy of Cancer;2023-09